212 related articles for article (PubMed ID: 19066953)
1. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
2. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
3. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
4. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens.
Manfrin E; Parisi A; Stefanizzi L; D'Onofrio M; Bernardoni L; Crino SF; Pelosi G; Pancione M; Giordano G; Sina S; Remo A
Pathol Res Pract; 2021 Oct; 226():153593. PubMed ID: 34481211
[TBL] [Abstract][Full Text] [Related]
5. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
8. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas.
Uhlig R; Contreras H; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Wilczak W; Izbicki J; Perez D; Schrader J; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R; Minner S; Jacobsen F; Clauditz TS
Am J Surg Pathol; 2022 Jan; 46(1):97-104. PubMed ID: 34889867
[TBL] [Abstract][Full Text] [Related]
9. Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report.
Ohno A; Sato Y; Nakamura E; Noguchi H; Tokumitsu T; Hiyoshi M; Nanashima A; Asada Y
Diagn Cytopathol; 2017 Mar; 45(3):247-251. PubMed ID: 27860444
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
[TBL] [Abstract][Full Text] [Related]
11. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.
Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
[TBL] [Abstract][Full Text] [Related]
12. CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas.
Uhlig R; Bröker N; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Lennartz M; Reiswich V; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Burandt E; Krech R; Dum D; Marx A; Simon R; Krech T; Clauditz TS; Jacobsen F
PLoS One; 2023; 18(6):e0287528. PubMed ID: 37379306
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic acinar cell carcinoma is associated with
Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic-type acinar cell carcinoma of the stomach beneath a focus of pancreatic metaplasia of the gastric mucosa.
Ambrosini-Spaltro A; Potì O; De Palma M; Filotico M
Hum Pathol; 2009 May; 40(5):746-9. PubMed ID: 19144387
[TBL] [Abstract][Full Text] [Related]
15. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
16. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.
Ishimoto-Namiki U; Ino Y; Esaki M; Shimada K; Saruta M; Hiraoka N
Am J Surg Pathol; 2023 May; 47(5):525-534. PubMed ID: 36815573
[TBL] [Abstract][Full Text] [Related]
17. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
18. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
19. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
20. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
